Page 1309 - Clinical Immunology_ Principles and Practice ( PDFDrive )

CHaPter 93 Assessment of Functional Immune Responses in Lymphocytes 1271

18. Sun JC, Lanier LL. NK cell development, homeostasis and function: T-cells induced by human tolerogenic dendritic cells. Scand J Immunol
parallels with CD8(+) T cells. Nat Rev Immunol 2011;11(10):645–57. 2010;72(2):158–68.
19. Yu TK, Caudell EG, Smid C, et al. IL-2 activation of NK cells: 36. Canavan JB, Afzali B, Scotta C, et al. A rapid diagnostic test for human
involvement of MKK1/2/ERK but not p38 kinase pathway. J Immunol regulatory T-cell function to enable regulatory T-cell therapy. Blood
2000;164(12):6244–51. 2012;119(8):e57–66.
20. Gasteiger G, Hemmers S, Firth MA, et al. IL-2-dependent tuning of NK 37. Ruitenberg JJ, Boyce C, Hingorani R, et al. Rapid assessment of in vitro
cell sensitivity for target cells is controlled by regulatory T cells. J Exp expanded human regulatory T cell function. J Immunol Methods
Med 2013;210(6):1167–78. 2011;372(1-2):95–106.
21. Somanchi SS, McCulley KJ, Somanchi A, et al. A Novel Method for 38. McMurchy AN, Levings MK. Suppression assays with human T regulatory
Assessment of Natural Killer Cell Cytotoxicity Using Image Cytometry. cells: a technical guide. Eur J Immunol 2012;42(1):27–34.
PLoS ONE 2015;10(10):e0141074. 39. Mason GM, Lowe K, Melchiotti R, et al. Phenotypic Complexity of the
22. Guldevall K, Brandt L, Forslund E, et al. Microchip Screening Platform Human Regulatory T Cell Compartment Revealed by Mass Cytometry.
for Single Cell Assessment of NK Cell Cytotoxicity. Front Immunol J Immunol 2015;195(5):2030–7.
2016;7:119. 40. Krutzik PO, Trejo A, Schulz KR, et al. Phospho flow cytometry methods
23. Jang YY, Cho D, Kim SK, et al. An improved flow cytometry-based for the analysis of kinase signaling in cell lines and primary human blood
natural killer cytotoxicity assay involving calcein AM staining of effector samples. Methods Mol Biol 2011;699:179–202.
cells. Ann Clin Lab Sci 2012;42(1):42–9. 41. Fleisher TA, Dorman SE, Anderson JA, et al. Detection of intracellular
24. Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the phosphorylated STAT-1 by flow cytometry. Clin Immunol
identification of natural killer cell activity. J Immunol Methods 1999;90(3):425–30.
2004;294(1-2):15–22. 42. Murphy J, Goldberg GL. Flow cytometric analysis of STAT
25. Betts MR, Brenchley JM, Price DA, et al. Sensitive and viable phosphorylation. Methods Mol Biol 2013;967:161–5.
identification of antigen-specific CD8+ T cells by a flow cytometric assay 43. Wahl MI, Fluckiger AC, Kato RM, et al. Phosphorylation of two
for degranulation. J Immunol Methods 2003;281(1-2):65–78. regulatory tyrosine residues in the activation of Bruton’s tyrosine
26. Bryceson YT, Pende D, Maul-Pavicic A, et al. A prospective evaluation of kinase via alternative receptors. Proc Natl Acad Sci USA
degranulation assays in the rapid diagnosis of familial hemophagocytic 1997;94(21):11526–33.
syndromes. Blood 2012;119(12):2754–63. 44. Panier S, Boulton SJ. Double-strand break repair: 53BP1 comes into
27. Yamashita M, Kitano S, Aikawa H, et al. A novel method for evaluating focus. Nat Rev Mol Cell Biol 2014;15(1):7–18.
antibody-dependent cell-mediated cytotoxicity by flowcytometry using 45. Paull TT. Mechanisms of ATM Activation. Annu Rev Biochem
cryopreserved human peripheral blood mononuclear cells. Sci Rep 2015;84:711–38.
2016;6:19772. 46. Kuo LJ, Yang LX. Gamma-H2AX - a novel biomarker for DNA
28. Ohkura N, Kitagawa Y, Sakaguchi S. Development and maintenance of double-strand breaks. In Vivo 2008;22(3):305–9.
regulatory T cells. Immunity 2013;38(3):414–23. 47. Abraham RS. Relevance of antibody testing in patients with recurrent
29. Sakaguchi S, Miyara M, Costantino CM, et al. FOXP3+ regulatory T cells infections. J Allergy Clin Immunol 2012;130(2):558–9, e6.
in the human immune system. Nat Rev Immunol 2010;10(7):490–500. 48. Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev
30. Schmitt EG, Williams CB. Generation and function of induced regulatory Immunol 2012;30:221–41.
T cells. Front Immunol 2013;4:152. 49. Rosser EC, Mauri C. Regulatory B cells: origin, phenotype, and function.
31. Barzaghi F, Passerini L, Bacchetta R. Immune dysregulation, Immunity 2015;42(4):607–12.
polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of 50. Lin W, Cerny D, Chua E, et al. Human regulatory B cells combine
immunodeficiency with autoimmunity. Front Immunol 2012;3:211. phenotypic and genetic hallmarks with a distinct differentiation fate. J
32. Beres AJ, Drobyski WR. The role of regulatory T cells in the biology of Immunol 2014;193(5):2258–66.
graft versus host disease. Front Immunol 2013;4:163. 51. Flores-Borja F, Bosma A, Ng D, et al. CD19+CD24hiCD38hi B cells
33. Li XC, Turka LA. An update on regulatory T cells in transplant tolerance maintain regulatory T cells while limiting TH1 and TH17 differentiation.
and rejection. Nat Rev Nephrol 2010;6(10):577–83. Sci Transl Med 2013;5(173):173ra23.
34. Waldmann H, Hilbrands R, Howie D, et al. Harnessing FOXP3+ 52. Nouel A, Simon Q, Jamin C, et al. Regulatory B cells: an exciting
regulatory T cells for transplantation tolerance. J Clin Invest target for future therapeutics in transplantation. Front Immunol
2014;124(4):1439–45. 2014;5:11.
35. Boks MA, Zwaginga JJ, van Ham SM, et al. An optimized CFSE-based 53. Sarantopoulos S, Blazar BR, Cutler C, et al. B cells in chronic graft-versus-
T-cell suppression assay to evaluate the suppressive capacity of regulatory host disease. Biol Blood Marrow Transplant 2015;21(1):16–23.